Standout Papers

<i>NRAS</i> mutation status is an independent prognostic factor in metastatic melanoma 2011 2026 2016 2021 524
  1. NRAS mutation status is an independent prognostic factor in metastatic melanoma (2011)
    John Jakob, Roland L. Bassett et al. Cancer

Immediate Impact

2 by Nobel laureates 10 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Thyroid Cancer
2024 Standout
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations
2023 Standout
3 intermediate papers

Works of John Jakob being referenced

NRAS mutation status is an independent prognostic factor in metastatic melanoma
2011 Standout

Author Peers

Author Last Decade Papers Cites
John Jakob 557 532 144 12 800
Robert D. Van Horn 293 344 195 20 688
Heiko Maacke 489 650 151 21 893
Leslie Smetzer 463 560 140 14 878
Fleur Weeber 709 301 104 10 973
Erin McNamara 613 331 87 18 952
Alexander Puhl 341 368 79 16 907
Monica Kong-Beltran 220 466 240 11 901
J F Flores 558 543 70 11 949
MacLean Hall 619 305 63 20 788
Earl Avramis 698 340 99 15 965

All Works

Loading papers...

Rankless by CCL
2026